|
1
|
European Association For The Study Of The
Liver1; European Organisation For Research And Treatment Of Cancer:
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao H, Phan H and Yang LX: Improved
chemotherapy for hepatocellular carcinoma. Anticancer Res.
32:1379–1386. 2012.PubMed/NCBI
|
|
3
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nordenstedt H, White DL and El-Serag HB:
The changing pattern of epidemiology in hepatocellular carcinoma.
Dig Liver Dis. 42(Suppl 3): S206–S214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roxburgh P and Evans TR: Systemic therapy
of hepatocellular carcinoma: Are we making progress? Adv Ther.
25:1089–1104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fernández M, Semela D, Bruix J, Colle I,
Pinzani M and Bosch J: Angiogenesis in liver disease. J Hepatol.
50:604–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jia YL, Shi L, Zhou JN, Fu CJ, Chen L,
Yuan HF, Wang YF, Yan XL, Xu YC, Zeng Q, et al: Epimorphin promotes
human hepatocellular carcinoma invasion and metastasis through
activation of focal adhesion kinase/extracellular signal-regulated
kinase/matrix metalloproteinase-9 axis. Hepatology. 54:1808–1818.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sancho Bru P, Juez E, Moreno M, Khurdayan
V, Morales-Ruiz M, Colmenero J, Arroyo V, Brenner DA, Ginés P and
Bataller R: Hepatocarcinoma cells stimulate the growth, migration
and expression of pro-angiogenic genes in human hepatic stellate
cells. Liver Int. 30:31–41. 2010. View Article : Google Scholar
|
|
10
|
Amann T, Bataille F, Spruss T, Mühlbauer
M, Gäbele E, Schölmerich J, Kiefer P, Bosserhoff AK and Hellerbrand
C: Activated hepatic stellate cells promote tumorigenicity of
hepatocellular carcinoma. Cancer Sci. 100:646–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Olaso E, Salado C, Egilegor E, Gutierrez
V, Santisteban A, Sancho-Bru P, Friedman SL and Vidal-Vanaclocha F:
Proangiogenic role of tumor-activated hepatic stellate cells in
experimental melanoma metastasis. Hepatology. 37:674–685. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Holopainen T, Huang H, Chen C, Kim KE,
Zhang L, Zhou F, Han W, Li C, Yu J, Wu J, et al: Angiopoietin-1
overexpression modulates vascular endothelium to facilitate tumor
cell dissemination and metastasis establishment. Cancer Res.
69:4656–4664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji Y, Wang Z, Li Z, Li K, Le X and Zhang
T: Angiotensin II induces angiogenic factors production partly via
AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells. Cell
Physiol Biochem. 29:863–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Augustin HG, Koh GY, Thurston G and
Alitalo K: Control of vascular morphogenesis and homeostasis
through the angiopoietin-Tie system. Nat Rev Mol Cell Biol.
10:165–177. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang H, Bhat A, Woodnutt G and Lappe R:
Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer.
10:575–585. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Forbes SJ and Parola M: Liver fibrogenic
cells. Best Pract Res Clin Gastroenterol. 25:207–217. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taura K, De Minicis S, Seki E, Hatano E,
Iwaisako K, Osterreicher CH, Kodama Y, Miura K, Ikai I, Uemoto S
and Brenner DA: Hepatic stellate cells secrete angiopoietin 1 that
induces angiogenesis in liver fibrosis. Gastroenterology.
135:1729–1738. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang XW, Cai CL, Xu JM, Jin H and Xu ZY:
Increased expression of chitinase 3-like 1 is a prognosis marker
for non-small cell lung cancer correlated with tumor angiogenesis.
Tumour Biol. 36:901–907. 2015. View Article : Google Scholar
|
|
19
|
Ding S, Li C, Lin S, Yang Y, Liu D, Han Y,
Zhang Y, Li L, Zhou L and Kumar S: Comparative evaluation of
microvessel density determined by CD34 or CD105 in benign and
malignant gastric lesions. Hum Pathol. 37:861–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sluimer JC and Daemen MJ: Novel concepts
in atherogenesis: Angiogenesis and hypoxia in atherosclerosis. J
Pathol. 218:7–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gong Y, Sun X, Huo L, Wiley EL and Rao MS:
Expression of cell adhesion molecules, CD44s and E-cadherin, and
microvessel density in invasive micropapillary carcinoma of the
breast. Histopathology. 46:24–30. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wynn TA: Cellular and molecular mechanisms
of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar
|
|
24
|
Sokolović A, Sokolović M, Boers W,
Elferink RP and Bosma PJ: Insulin-like growth factor binding
protein 5 enhances survival of LX2 human hepatic stellate cells.
Fibrogenesis Tissue Repair. 3:32010. View Article : Google Scholar
|
|
25
|
Stoeltzing O, Ahmad SA, Liu W, McCarty MF,
Wey JS, Parikh AA, Fan F, Reinmuth N, Kawaguchi M, Bucana CD and
Ellis LM: Angiopoietin-1 inhibits vascular permeability,
angiogenesis, and growth of hepatic colon cancer tumors. Cancer
Res. 63:3370–3377. 2003.PubMed/NCBI
|
|
26
|
Thomas M and Augustin HG: The role of the
Angiopoietins in vascular morphogenesis. Angiogenesis. 12:125–137.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Machein MR, Knedla A, Knoth R, Wagner S,
Neuschl E and Plate KH: Angiopoietin-1 promotes tumor angiogenesis
in a rat glioma model. Am J Pathol. 165:1557–1570. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Valfrè di Bonzo L, Novo E, Cannito S,
Busletta C, Paternostro C, Povero D and Parola M: Angiogenesis and
liver fibrogenesis. Histol Histopathol. 24:1323–1341.
2009.PubMed/NCBI
|
|
29
|
Medina J, Arroyo AG, Sánchez-Madrid F and
Moreno-Otero R: Angiogenesis in chronic inflammatory liver disease.
Hepatology. 39:1185–1195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Novo E, Cannito S, Zamara E, Valfrè di
Bonzo L, Caligiuri A, Cravanzola C, Compagnone A, Colombatto S,
Marra F, Pinzani M and Parola M: Proangiogenic cytokines as
hypoxia-dependent factors stimulating migration of human hepatic
stellate cells. Am J Pathol. 170:1942–1953. 2007. View Article : Google Scholar : PubMed/NCBI
|
